Approach to difficult-to-treat asthma in childhood: a narrative review

Duo-Tong Cheng1, Liang Yi Justin Wee, Oon Hoe Teoh

  • 1Department of Paediatrics, Respiratory Medicine Service, KK Women's and Children's Hospital, Singapore.

Singapore Medical Journal
|February 16, 2024
PubMed

Insights

This review focuses on managing difficult-to-treat pediatric asthma. Personalized strategies, addressing comorbidities, and adherence are key to improving asthma control in children.

Area of Science:

  • Pediatric Pulmonology
  • Allergy and Immunology

Background:

  • Difficult-to-treat asthma in children significantly impacts healthcare resources.
  • Accurate diagnosis and management are crucial for effective treatment.

Purpose of the Study:

  • To provide an updated overview of treatment strategies for difficult-to-treat pediatric asthma.
  • To emphasize personalized approaches and the role of biologics.

Main Methods:

  • Comprehensive literature review of current treatment guidelines and research.
  • Analysis of factors influencing asthma control in children.
  • Evaluation of diagnostic criteria and management of comorbidities.

Main Results:

  • Ruling out asthma mimics and confirming diagnosis with objective tests are essential.
  • Comorbidities like obesity, smoking, and psychosocial factors must be considered.
  • Personalized treatment, adherence monitoring, and appropriate drug delivery are vital.

Conclusions:

  • Biologics are an option for select patients but do not replace adherence improvement.
  • Many cases of difficult-to-treat asthma are not severe asthma.
  • An individualized approach involving physicians, patients, and families is key to achieving good asthma control.

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
297
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
398
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
206
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
298